Adapthealth Corp Stock Price, News & Analysis

AdaptHealth (NASDAQ: AHCO) announced Q1 2021 financial results, showing net revenue of $482.1 million, up 152% year-over-year. The company reported a net loss of $4.0 million or $0.08 per diluted share, an improvement from a $34.6 million loss in Q1 2020. Adjusted EBITDA soared 242% to $104.2 million. Following the acquisition of AeroCare and other strategic purchases, the company increased its 2021 guidance, now projecting revenues of $2.22 billion to $2.39 billion and adjusted EBITDA of $525 million to $565 million.

AdaptHealth Corp. (NASDAQ: AHCO) has successfully amended its senior secured credit facilities, increasing its term loan by $100 million and expanding its revolving credit capacity from $250 million to $450 million. The additional funds will primarily be used to repay existing revolving credit borrowings and facilitate acquisitions. The company's Co-CEO emphasized their growth strategy following the combination with AeroCare and highlighted the completion of 245 acquisitions since 2012. These changes are expected to enhance operational efficiencies and support future growth.

AdaptHealth Corp. (NASDAQ: AHCO) announced it will release its financial results for Q1 2021 on May 6, 2021, prior to market opening. A conference call is scheduled for the same day at 8:30 am ET to discuss the results. The company specializes in providing patient-centric, technology-enabled chronic disease management, serving nearly 3 million patients annually across 500+ locations in 46 states. The offerings include sleep therapy equipment, diabetes management products, home medical equipment, and chronic therapy services.

AdaptHealth Corp. (NASDAQ: AHCO) has announced that Co-CEO Luke McGee has been charged with tax fraud related to personal conduct from March 2014 to August 2015, unrelated to the company's operations. McGee is on unpaid leave pending the outcome. The Board expresses full confidence in the management team led by Co-CEO Steve Griggs and President Josh Parnes to uphold business strength and growth. AdaptHealth provides home healthcare solutions nationwide, serving approximately 1.8 million patients annually across its 269 locations.

AdaptHealth Corp. (NASDAQ: AHCO) reported strong financial results for Q4 and FY 2020. Q4 net revenue reached $348.4 million, a 133% increase year-over-year, while FY revenue hit $1.06 billion, up 99%. However, the company experienced a net loss of $31.0 million in Q4 and $64.5 million for the full year, primarily due to non-cash charges. AdaptHealth has closed the acquisition of AeroCare and anticipates $50 million in annual cost synergies. The company raised its 2021 guidance, projecting net revenue of $2.18 to $2.35 billion.

AdaptHealth Corp. (NASDAQ: AHCO), a top provider of home medical equipment in the U.S., announced that its Co-CEOs, Luke McGee and Steve Griggs, along with CFO Jason Clemens, will present at two upcoming investor conferences.

• SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021, at 3:00 p.m. ET.
• J.P. Morgan Global High Yield & Leveraged Finance Conference on March 3, 2021, at 11:30 a.m. ET.

Live webcasts will be available on AdaptHealth’s website. The company serves nearly 3 million patients annually through a network of over 500 locations across 46 states.

AdaptHealth Corp. (NASDAQ: AHCO) will announce its financial results for Q4 and full year 2020 on March 4, 2021, before market opening. A conference call is scheduled for 8:30 am ET that same day to discuss the results and business activities. Interested parties can join by calling either (877) 423-9820 (Domestic) or (201) 493-6749 (International). After the call, a replay will be available on the Company’s website for six months under 'Investor Relations.'

AeroCare Holdings has been acquired by AdaptHealth Corp. in a deal valued at approximately $1.1 billion in cash and 31 million shares of stock. This acquisition allows AeroCare’s shareholders, including management and private investors, to become shareholders of AdaptHealth. AeroCare provides home medical equipment and services to over 1 million patients annually, showcasing 20 years of consecutive revenue growth. The merger is anticipated to enhance operational efficiencies and market leadership in the healthcare sector, addressing the needs of chronically ill patients.

AdaptHealth Corp. (NASDAQ: AHCO) has completed its acquisition of AeroCare Holdings Inc. for approximately $1.1 billion in cash and stock, enhancing its home healthcare services. The deal includes 31 million shares of AdaptHealth common stock, subject to shareholder approval. This acquisition enables AdaptHealth to reach nearly 3 million patients across 46 states through over 500 locations. The company will be co-led by AdaptHealth CEO Luke McGee and AeroCare CEO Steve Griggs while expanding its Board of Directors. The transaction was funded through senior notes and credit facility adjustments.